Simultaneous determination of L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in the plasma of rodents with LC-MS/MS

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 6, 2011, Pages 340-346

  Chae, Jung Woo ^a   Baek, In Hwan ^a   Kang, Wonku ^b   Kwon, Kwang Il ^a  

^a Chungnam National University   (South Korea)

^b Daegu University   (South Korea)

Author keywords

Asymmetric dimethylarginine; Cardiovascular drug; L Arginine; Symmetric dimethylarginine

Indexed keywords

ARGININE; DIMETHYLARGININASE; METHAQUALONE; N(G),N(G) DIMETHYLARGININE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; VALIDATION STUDY;

EID: 79960372599     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296208     Document Type: Article

References (32)

1. Gryglewski RJ, Botting RM, Vane JR. Mediators produced by the endothelial cell. Hypertension. 1988 Dec;12(6):530-48. (Pubitemid 19030498)
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002-12. (Pubitemid 24015045)
3. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251-6.
4. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992 Mar 7;339(8793):572-5.
5. Aisaka K, Gross SS, Griffith OW, Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun. 1989 Apr 28;160(2):881-6.
6. Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nat Rev Drug Discov. 2002 Dec;1(12):939-50.
7. Gehrig PM, Hunziker PE, Zahariev S, Pongor S. Fragmentation pathways of N(G)-methylated and unmodified arginine residues in peptides studied by ESI-MS/MS and MALDI-MS. J Am Soc Mass Spectrom. 2004 Feb;15(2):142-9. (Pubitemid 38183202)
8. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G. Serumconcentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int Suppl. 2001 Feb;78:S14-8.
9. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999 Mar 9;99(9):1141-6. (Pubitemid 29120084)
10. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000 Sep;20(9):2032-7.
11. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997 Apr 15;95(8):2068-74. (Pubitemid 27184275)
12. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998 Nov 3;98(18):1842-7. (Pubitemid 28509278)
13. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, et al. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol. 1999 Mar;10(3):594-600. (Pubitemid 29117641)
14. Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, et al. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism. 1997 Sep;46(9):1024-31. (Pubitemid 27371819)
15. MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant. 1996 Dec;11(12):2449-52. (Pubitemid 27033779)
16. Schmidt RJ, Domico J, Samsell LS, Yokota S, Tracy TS, Sorkin MI, et al. Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis. 1999 Aug;34(2):228-34. (Pubitemid 29362085)
17. Al Banchaabouchi M, Marescau B, Possemiers I, D'Hooge R, Levillain O, De Deyn PP. NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency. Pflugers Arch. 2000 Mar;439(5):524-31.
18. Schmidt RJ, Baylis C. Total nitric oxide production is lowin patients with chronic renal disease. Kidney Int. 2000 Sep; 58(3):1261-6.
19. Goonasekera CD, Shah V, Rees DD, Dillon MJ. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Blood Press. 2000;9(1):16-21.
20. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol. 1999 Apr;33(4):652-8. (Pubitemid 29164831)
21. Tsao PS, Cooke JP. Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction. J Cardiovasc Pharmacol. 1998;32 Suppl 3:S48-53. Review.
22. Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1557-64. (Pubitemid 30353888)
23. Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001 Dec 22-29;358(9299):2127-8. (Pubitemid 34094905)
24. Post MS, Verhoeven MO, van der Mooren MJ, Kenemans P, Stehouwer CD, Teerlink T. Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. J Clin Endocrinol Metab. 2003 Sep;88(9):4221-6. (Pubitemid 37153723)
25. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002 Mar 20;287(11):1420-6. (Pubitemid 34250505)
26. Nestorov I, Graham G, Duffull S, Aarons L, Fuseau E, Coates P. Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan. Pharm Res. 2001 Aug;18(8):1210-9. (Pubitemid 32900408)
27. Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, Stehouwer CD, et al. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant. 2003 Dec;18(12):2542-50. (Pubitemid 37483787)
28. Dobashi Y, Santa T, Nakagomi K, Imai K. An automated analyzer for methylated arginines in rat plasma by high-performance liquid chromatography with post-column fluorescence reaction. Analyst. 2002 Jan;127(1):54-9. (Pubitemid 34081631)
29. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes. 2005 Nov;54(11):3282-7. (Pubitemid 43334386)
30. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002 Aug 20;106(8):987-92. (Pubitemid 34925335)
31. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Böger RH. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):211-9. Epub 2006 Dec 27. (Pubitemid 46720141)
32. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med. 2004;42(12):1377-83. (Pubitemid 40057825)